1 | Administration OF A high dose OF desipramine | - | - | - | - | 1件: 156 156 💬
|
2 | Administration OF A LOW dose OF desipramine | - | - | - | - | 1件: 156 156 💬
|
3 | Alac, inulin, FOS, and sodium butyrate | 1件: Butyric Acid Butyric Acid | 1件: Sodium butyrate
Sodium butyrate
💬
| - | - | 1件: 156 156 💬
|
4 | Alpha-tocotrienol quinone | 1件: Vatiquinone Vatiquinone | 1件: Vatiquinone
Vatiquinone
💬
| - | - | 3件: 18 18, 21, 156 💬
|
5 | Anavex2-73 | 1件: Blarcamesine Blarcamesine | 2件: Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| 15件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 156 💬
|
6 | Anavex2-73 oral liquid | 1件: Blarcamesine Blarcamesine | 2件: Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| 15件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 156 156 💬
|
7 | Bionetide | - | - | - | - | 1件: 156 156 💬
|
8 | Blarcamesine | 1件: Blarcamesine Blarcamesine | 2件: Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| 15件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 156 156 💬
|
9 | Calcium | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 12件: 6 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
|
10 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
|
11 | Cannabidiolo | - | - | - | - | 1件: 156 156 💬
|
12 | CBD | - | - | - | - | 9件: 6 6, 8, 13, 36, 140, 144, 145, 156, 158 💬
|
13 | CBD - oral solution, IS known AS epidyolex, and IS THE approved name | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
14 | CBD - solution orale, conosciuto come epidiolex, questo è IL nome approvato negli stati uniti | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
15 | CBD oral solution, IS known AS epidyolex and IS THE approved name IN THE EU | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
16 | CBD soluzione orale nota come epidyolex E CON tale nome è stato approvato IN UE | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
17 | Creatine monohydrate | 1件: Creatine Creatine | - | - | - | 5件: 2 2, 8, 97, 113, 156 💬
|
18 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 6 6, 8, 13, 21, 85, 96, 97, 156 💬
|
19 | Donepezil | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 8件: 5 5, 6, 13, 46, 124, 127, 156, 206 💬
|
20 | Donepezil hydrochloride | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 3件: 6 6, 124, 156 💬
|
21 | EMD 128130 | - | - | - | - | 2件: 6 6, 156 💬
|
22 | EPI-743 | - | - | - | - | 3件: 21 21, 156, 337 💬
|
23 | Epidyolex and IS THE approved name IN THE EU | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 156 156 💬
|
24 | Esketamine hydrochloride | 1件: Esketamine Esketamine | 2件: Esketamine
Esketamine
,
Esketamine hydrochloride
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 70 70, 156 💬
|
25 | Fingolimod | 1件: Fingolimod Fingolimod | 3件: Fingolimod hydrochloride
Fingolimod hydrochloride
,
Fingolimod
,
Fingolimod lauryl sulfate
💬
| 1件: S1PR1 S1PR1 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 14, 156 💬
|
26 | GCB-002 | - | - | - | - | 1件: 156 156 💬
|
27 | Glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 3件: 13 13, 96, 156 💬
|
28 | Growth hormone | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 16件: 2 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
|
29 | GWP42003-P | - | - | - | - | 6件: 140 140, 143, 144, 145, 156, 158 💬
|
30 | Human insulin | 1件: Insulin human Insulin human | 1件: Insulin human
Insulin human
💬
| 1件: INSR INSR 💬
| 23件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Hormone signaling, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 156 156 💬
|
31 | Intrathecal injection OF AAV-MECP2 FOR THE treatment OF rett syndrome | - | - | - | - | 1件: 156 156 💬
|
32 | Ketamine | 1件: Ketamine Ketamine | 2件: Ketamine hydrochloride
Ketamine hydrochloride
,
Ketamine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 6件: 6 6, 13, 70, 113, 156, 215 💬
|
33 | Lovastatin | 1件: Lovastatin Lovastatin | 1件: Lovastatin
Lovastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
|
34 | Male rett | - | - | - | - | 1件: 156 156 💬
|
35 | NGN-401 | 1件: NGN-401 NGN-401 | - | - | - | 1件: 156 156 💬
|
36 | NNZ-2566 | - | - | - | - | 2件: 156 156, 206 💬
|
37 | NTI164 | - | - | - | - | 1件: 156 156 💬
|
38 | Probiotic-lactobacillus plantarum PS128 | - | - | - | - | 1件: 156 156 💬
|
39 | RETT-T | - | - | - | - | 1件: 156 156 💬
|
40 | Rhigf-1 | - | - | - | - | 1件: 156 156 💬
|
41 | Risperidone | 1件: Risperidone Risperidone | 1件: Risperidone
Risperidone
💬
| 2件: DRD2 DRD2, HTR2 💬
| 13件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 3件: 8 8, 156, 187 💬
|
42 | Sarizotan | 1件: Sarizotan Sarizotan | 1件: Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| 2件: DRD2 DRD2, HTR1 💬
| 12件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 156 💬
|
43 | Sarizotan cloridrato | 1件: Sarizotan Sarizotan | 1件: Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| 2件: DRD2 DRD2, HTR1 💬
| 12件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 156 156 💬
|
44 | Sarizotan hydrochloride | 1件: Sarizotan Sarizotan | 1件: Sarizotan hydrochloride
Sarizotan hydrochloride
💬
| 2件: DRD2 DRD2, HTR1 💬
| 12件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 156 💬
|
45 | Sodium butyrate and zinc oxide | 1件: Butyric Acid Butyric Acid | 1件: Sodium butyrate
Sodium butyrate
💬
| - | - | 1件: 156 156 💬
|
46 | Topiramate | 1件: Topiramate Topiramate | 1件: Topiramate
Topiramate
💬
| 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 140, 144, 156, 193 💬
|
47 | Tridecanoic acid | - | - | - | - | 1件: 156 156 💬
|
48 | Triheptanoin | 1件: Triheptanoin Triheptanoin | 1件: Triheptanoin
Triheptanoin
💬
| - | - | 10件: 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬
|
49 | Trofinetide | 1件: Trofinetide Trofinetide | 1件: Trofinetide
Trofinetide
💬
| - | - | 1件: 156 156 💬
|
50 | TSHA-102 | 1件: TSHA-102 TSHA-102 | - | - | - | 1件: 156 156 💬
|
51 | VYNT-0126 | - | - | - | - | 1件: 156 156 💬
|